Tumors of the nervous system are the most common type of solid childhood tumors, comprising about 21 percent of all childhood neoplasms. Approximately 3,000 children every year are diagnosed with brain tumors in the U.S. Surgery is the most common treatment for these children. Over the past 20 years, due to advancements in surgical techniques and adjunctive therapies, children with tumors of the nervous system have experienced significant improvement in survival rates and outcomes. Today, researchers have begun to unveil the molecular and genetic causes of these tumors, which has led to promising new therapies with the potential to further improve outcomes. However, current treatment and prognosis for recovery depends on several factors, including the type of tumor, its location, and the general health and age of the child.
In this potentially overwhelming and stressful time, the entire staff at ANA is here to provide you with clear and comprehensive explanations, expert diagnosis or a second opinion, as well as treatment options.
It is important that if you or someone you know suspects a brain tumor, you seek medical attention. Persistent symptoms warrant an MRI or CT scan in order to gain a diagnosis. The earlier a brain tumor is detected and treated, the better the odds of increased survival.
The predominant symptom of both benign and malignant spinal tumors is back pain not attributed to injury or stress and located especially in the middle or lower back. The pain may increase with activity and is often worse at night. The pain may also worsen over time, as well as spread to the hips, legs, feet or arms.
Depending on the type and location of the tumor, other symptoms may occur, and can include the following:
ANA has access to a wide range of clinical trials, to which our experts can guide a patient whenever beneficial and relevant. Clinical trials are rigorously controlled tests of new drugs or medical devices or procedures. In the U.S., these trials are conducted under the direction of the FDA before they are made available for general clinical use.
Besides helping to develop future treatments with your child’s participation, the benefits of clinical trials with ANA is that you gain access to treatments that are not yet widely available. Moreover, in the case of pediatric cancer, clinical trials are a key factor in improving both treatments and prognosis.
Your team at ANA will explain the meaning and goals of Phase 1, 2 and 3 clinical trials, as well as the benefits and risks of participation in any relevant trial. As always, our goal is to build your trust by way of informing and including you.
Pediatric Clinic Trials Resource
The Children’s Oncology Group (COG) http://www.childrensoncologygroup.org/